Q3 2021

Source filing unavailable

Q3 2021 · —

Revenue

€4.44B

+0.6% vs Q3 2020

Net Income

€273.04M

−22.8% vs Q3 2020

EPS Diluted

€0.93

−23.1% vs Q3 2020

Gross Profit€1,267,217,000−7.3%

Operating Income€504,661,000−20.1%

Operating Cash Flowderived

Same quarter

Metric	Q3 2021	Q3 2020	Q3 2019	Q3 2018
Revenue	€4.44B	€4.41B	€4.42B	€4.06B
Net Income	€273.04M	€353.50M	€332.58M	€284.61M
EPS Diluted	€0.93	€1.21	€1.10	€0.93

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR